Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bioretec Oy, a medical device company, (BRETEC) Fair Value & Analysis

Healthcare · FI · Market cap €30.3M

Price€0.0230
Fair Value€0.0200
Upside-13.0%
Quality95/100
Evidence: Low

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bioretec Oy, a medical device company, (BRETEC) currently trades at €0.0230, while our model-based Fair Value estimate is €0.0200 — implying the stock looks roughly 13.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. Th…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -9% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Bioretec Oy, a medical device company, (BRETEC) undervalued?
As of Jun 26, 2026, our model estimates a fair value of €0.0200 versus a price of €0.0230 — about −13% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BRETEC?
Our 21-model fair value for Bioretec Oy, a medical device company, is €0.0200 (as of Jun 26, 2026), built from audited fundamentals. The current price is €0.0230.
What is the quality score of BRETEC?
Bioretec Oy, a medical device company, has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.